Copyright
©2007 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 7, 2007; 13(45): 6041-6047
Published online Dec 7, 2007. doi: 10.3748/wjg.v13.i45.6041
Published online Dec 7, 2007. doi: 10.3748/wjg.v13.i45.6041
Figure 5 Mast cells after staining by mouse anti-human tryptase antibody under a powerful microscope (× 400).
A-C: Mast cells at the descending part of the duodenum in healthy controls, IBS-C patients and IBS-D patients, respectively; D-F: Mast cells at the proximal end of jejunum in healthy controls, IBS-C patients and IBS-D patients, respectively; G-I: Mast cells at the terminal ileum in healthy controls, IBS-C patients and IBS-D patients, respectively. EC cell: Enterochromaffin cells; 5-HT: Serotonin; IBS: Irritable bowel syndrome; IBS-C: Constipation predominant IBS; IBS-D: Diarrhea predominant IBS.
- Citation: Wang SH, Dong L, Luo JY, Gong J, Li L, Lu XL, Han SP. Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome. World J Gastroenterol 2007; 13(45): 6041-6047
- URL: https://www.wjgnet.com/1007-9327/full/v13/i45/6041.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i45.6041